ES2065321T3 - Procedimiento para la transformacion de un precursor de insulina humana en insulina humana. - Google Patents

Procedimiento para la transformacion de un precursor de insulina humana en insulina humana.

Info

Publication number
ES2065321T3
ES2065321T3 ES87309011T ES87309011T ES2065321T3 ES 2065321 T3 ES2065321 T3 ES 2065321T3 ES 87309011 T ES87309011 T ES 87309011T ES 87309011 T ES87309011 T ES 87309011T ES 2065321 T3 ES2065321 T3 ES 2065321T3
Authority
ES
Spain
Prior art keywords
human insulin
procedure
transformation
precursor
insulin precursor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87309011T
Other languages
English (en)
Inventor
Bruce Hill Frank
Richard Eugene Heiney
Walter Francis Prouty
Mark Robert Walden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2065321T3 publication Critical patent/ES2065321T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ESTA ESPECIFICACION DESCRIBE UN PROCEDIMIENTO PARA TRANSFORMAR UN PRECURSOR DE INSULINA HUMANA EN INSULINA HUMANA, QUE CONSISTE EN TRATAR TAL PRECURSOR DE INSULINA HUMANA CON TRIPSINA Y CARBOXIPEPTIDASA B EN UN MEDIO ACUOSO QUE CONTIENE POR MOL DE PRECURSOR DE INSULINA HUMANA DE 0,1 A 10 MOLES APROXIMADAMENTE DE UNO O MAS IONES METALICOS DE LOS METALES QUE TIENEN NUMEROS ATOMICOS 21 A 34, 39 A 52, 57 A 87, Y 89 A 92.
ES87309011T 1986-10-14 1987-10-13 Procedimiento para la transformacion de un precursor de insulina humana en insulina humana. Expired - Lifetime ES2065321T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91793986A 1986-10-14 1986-10-14

Publications (1)

Publication Number Publication Date
ES2065321T3 true ES2065321T3 (es) 1995-02-16

Family

ID=25439543

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87309011T Expired - Lifetime ES2065321T3 (es) 1986-10-14 1987-10-13 Procedimiento para la transformacion de un precursor de insulina humana en insulina humana.

Country Status (26)

Country Link
US (1) US5457066A (es)
EP (1) EP0264250B1 (es)
JP (1) JP2634176B2 (es)
KR (1) KR970003519B1 (es)
CN (1) CN1029131C (es)
AR (1) AR243608A1 (es)
AT (1) ATE115962T1 (es)
AU (1) AU595934B2 (es)
CA (1) CA1339955C (es)
CY (1) CY1830A (es)
DE (1) DE3750897T2 (es)
DK (1) DK175266B1 (es)
EG (1) EG18520A (es)
ES (1) ES2065321T3 (es)
GR (1) GR3015143T3 (es)
HK (1) HK39495A (es)
HU (1) HU204572B (es)
IE (1) IE65972B1 (es)
IL (1) IL84110A (es)
MX (1) MX168305B (es)
NZ (1) NZ222082A (es)
PH (1) PH26471A (es)
PT (1) PT85892B (es)
RU (1) RU1829939C (es)
SG (1) SG14795G (es)
ZA (1) ZA877505B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130236A (en) * 1989-12-07 1992-07-14 Eli Lilly And Company Process for producing des(64,65)-proinsulin
IL99383A (en) * 1990-09-05 1996-01-31 Hoechst Ag Enzymatic process for the conversion of preproinsulins into insulins
NZ245170A (en) * 1991-11-26 1994-07-26 Lilly Co Eli Insulin and proinsulin analogues with arg at b31, b32 and ao and pharmaceutical compositions
CA2102673A1 (en) * 1992-11-13 1994-05-14 Michael G. Greaney Expression vectors for bovine trypsin and trypsinogen and host cells transformed therewith
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
US6068993A (en) * 1997-07-02 2000-05-30 Biobras Sa Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
US6087558A (en) * 1998-07-22 2000-07-11 Prodigene, Inc. Commercial production of proteases in plants
US6395299B1 (en) 1999-02-12 2002-05-28 Biostream, Inc. Matrices for drug delivery and methods for making and using the same
US7169889B1 (en) 1999-06-19 2007-01-30 Biocon Limited Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
US20020164712A1 (en) * 2000-12-11 2002-11-07 Tonghua Gantech Biotechnology Ltd. Chimeric protein containing an intramolecular chaperone-like sequence
US20030054015A1 (en) * 2000-12-25 2003-03-20 Shinichiro Haze Sympathetic-activating perfume composition
US7060675B2 (en) 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6867183B2 (en) 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US6713452B2 (en) * 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828305B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US6835802B2 (en) * 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US6858580B2 (en) * 2001-06-04 2005-02-22 Nobex Corporation Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6913903B2 (en) 2001-09-07 2005-07-05 Nobex Corporation Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7196059B2 (en) 2001-09-07 2007-03-27 Biocon Limited Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7312192B2 (en) 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7166571B2 (en) 2001-09-07 2007-01-23 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
DE60236014D1 (de) 2001-11-19 2010-05-27 Novo Nordisk As Verfahren zur herstellung von insulinverbindungen
EP1532262B1 (en) * 2002-05-24 2013-07-10 Medtronic, Inc. Peptide amidation process
AU2003243316A1 (en) * 2002-05-24 2003-12-12 Nps Allelix Corp. Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
AU2003276835A1 (en) * 2002-05-24 2004-02-16 Restoragen, Inc. Polypeptide cleavage process
AU2003236521A1 (en) * 2002-06-13 2003-12-31 Nobex Corporation Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
DE10235168A1 (de) 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
HRP20120315T1 (hr) * 2003-11-21 2012-05-31 Nps Pharmaceuticals Proizvodnja peptida 2 nalik glukagonu i analoga
ES2337684T3 (es) * 2003-12-05 2010-04-28 F. Hoffmann-La Roche Ag Carboxipeptidasa b recombinante y su purificacion.
RU2527893C2 (ru) 2004-07-19 2014-09-10 Биокон Лимитед Инсулин-олигомерные конъюгаты, их препараты и применения
RU2453332C2 (ru) 2007-10-16 2012-06-20 Байокон Лимитид Твердая фармацевтическая композиция (варианты) и способ контроля концентрации глюкозы с ее помощью, способ получения твердой фармацевтической композиции (варианты), таблетка (варианты) и способ получения амфорных частиц
EP2307441B1 (en) * 2008-08-07 2016-03-23 Biocon Limited A process for preparation of insulin compounds
WO2012104099A1 (en) * 2011-02-04 2012-08-09 Glucometrix Ag Process for the production of recombinant trypsin
WO2012115640A1 (en) 2011-02-23 2012-08-30 Elona Biotechnologies Liquid insulin- containing compositions and methods of making the same
KR20170036643A (ko) * 2015-09-24 2017-04-03 한미약품 주식회사 인슐린의 제조 방법
KR20200080747A (ko) * 2018-12-27 2020-07-07 주식회사 폴루스 인슐린 전구체의 인슐린 효소 전환용 조성물 및 이를 이용하여 인슐린 전구체를 인슐린으로 전환하는 방법
IL317049A (en) 2022-05-18 2025-01-01 Protomer Tech Inc Aromatic boron-containing compounds and related insulin analogs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5756878A (en) * 1980-09-22 1982-04-05 Sharp Corp Cleaning device
DK149824C (da) * 1982-01-22 1987-03-16 Carlsberg Biotechnology Ltd Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyrer i insuliner

Also Published As

Publication number Publication date
PT85892B (pt) 1990-07-31
ZA877505B (en) 1989-05-30
PT85892A (en) 1987-11-01
AR243608A1 (es) 1993-08-31
IL84110A (en) 1992-11-15
IE65972B1 (en) 1995-11-29
DK175266B1 (da) 2004-08-02
CA1339955C (en) 1998-07-14
SG14795G (en) 1995-06-16
PH26471A (en) 1992-07-27
RU1829939C (ru) 1993-07-23
AU7952887A (en) 1988-04-21
CY1830A (en) 1995-12-01
GR3015143T3 (en) 1995-05-31
KR970003519B1 (ko) 1997-03-18
NZ222082A (en) 1989-08-29
EP0264250A2 (en) 1988-04-20
CN1029131C (zh) 1995-06-28
US5457066A (en) 1995-10-10
CN87107019A (zh) 1988-04-27
EG18520A (en) 1993-04-30
JP2634176B2 (ja) 1997-07-23
HU204572B (en) 1992-01-28
DK528487A (da) 1988-04-15
IL84110A0 (en) 1988-03-31
KR880005262A (ko) 1988-06-28
HUT46363A (en) 1988-10-28
IE872743L (en) 1988-04-14
DK528487D0 (da) 1987-10-09
HK39495A (en) 1995-03-24
DE3750897D1 (de) 1995-02-02
DE3750897T2 (de) 1995-05-18
EP0264250B1 (en) 1994-12-21
JPS63105695A (ja) 1988-05-10
EP0264250A3 (en) 1990-03-21
AU595934B2 (en) 1990-04-12
MX168305B (es) 1993-05-17
ATE115962T1 (de) 1995-01-15

Similar Documents

Publication Publication Date Title
ES2065321T3 (es) Procedimiento para la transformacion de un precursor de insulina humana en insulina humana.
BR9206941A (pt) Métodos para o tratamento da osteoporose usando-se bifosfonatos e hormônio paratireóideo
BR9916544A (pt) Processo para tratamento de neoplasia em um indivìduo que necessita de tal tratamento, e, combinação
DE69031748D1 (de) Plasmabehandlung mit Metallmasken-Integration
NO20002409L (no) FremgangsmÕte for Õ produsere arsen trioksyd formuleringer og metoder for Õ behandle cancer ved Õ bruke arsen trioksyd eller melarsoprol
AR221506A1 (es) Procedimiento para producir dispersiones o soluciones acuosas de poliuretan-poliureas y las dispersiones o soluciones que se obtienen por medio de este procedimiento
DE3650447D1 (de) Gegenstand, insbesondere Uhrband od.dgl.
BR9916518A (pt) Método para tratar ou prevenir um distúrbio de neoplasia em um mamìfero em necessidade de tal tratamento ou prevenção, e, combinação compreendendo um inibidor de ciclooxigenase-2 e um ou mais agentes anti-neoplásticos
MX13817A (es) Procedimiento para la preparacion de polvos de oxidos mixtos metalicos.
ES489003A0 (es) Procedimiento para el tratamiento de boruracion de piezas hechas de metal o de cermets.
IT8122595A0 (it) Procedimento per il trattamento di lisato di limulo e reagente contenente il lisato trattato.
ES2164367T3 (es) Tratamiento superficial del metal.
ES466793A1 (es) Un procedimiento para la preparacion de derivados de imida- zol, con propiedades antiartriticas.
NL185170B (nl) Van een slot voorzien bevestigingsorgaan.
ATE108575T1 (de) Einrichtung zur verkleinernden oder 1 : 1 ionenprojektionslithographie.
SE8405559D0 (sv) Kombinerad handtags- och lasmekanism for panelmonterade apparater sasom bilradioapparater
MY106562A (en) Baths and process for the chemical polishing of stainless steel surfaces
IT8141637A0 (it) Procedimento per il rivestimento di elementi, come ad esempio elementi componenti di gioielli e orologi da polso placcati d'oro, e elementi rivestiti ottenuti.
DK0596273T3 (da) Middel til bejdsning af overflader af chromnikkelstål og chromstål og anvendelse af midlet
GB9318807D0 (en) Use of lectins for treatment of skin diseases
DE68911590D1 (de) Verschluss für Uhrarmbänder, Armbänder, Schmuckartikel oder dergleichen.
IT7821377A0 (it) Processo per il trattamento di gascontenente idrogeno solforato.
ATE112545T1 (de) Verfahren zur hydroxylierung von phenolen und phenolethern.
ES2066477T3 (es) Baño acido para la electrodeposicion de recubrimientos de cobre y procedimiento con utilizacion de esta combinacion.
GB2000755B (en) Processes for the treatment of metal bearing materials

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 264250

Country of ref document: ES